Multicenter Cohort Study of AAV in Hunan of China
Multicenter Cohort Study of ANCA-associated Small Vasculitis in Hunan Province of China
Xiangya Hospital of Central South University
500 participants
Mar 16, 2022
OBSERVATIONAL
Conditions
Summary
This study aimed to explore the incidence of Anti-neutrophil cytoplasmic antibody (ANCA）-associated vasculitis (AAV) progression and its association with adverse consequences. It will enroll approximately 500 AAV patients in Hunan province of China and follow-up for at least 5 years. Demographic characteristics, clinical and laboratory data will be collected at baseline and every follow-up. The principal clinical outcomes of the study consist of end stage renal disease (ESRD) and death.
Eligibility
Inclusion Criteria1
- Fulfill 2012 criteria of ANCA associated vasculitis and agree to sign informed consent
Exclusion Criteria1
- Do not agree to sign informed consent
Interventions
No Intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05315141